Automation of the In Vitro Fertilization Laboratory
150 patients around the world
Available in Mexico
Conceivable Life Sciences
3Research sites
150Patients around the world
This study is for people with
Infertility
Requirements for the patient
To 45 Years
All Gender
Medical requirements
Informed consent signed by the patients before treatment.
Medical indication to perform assisted reproductive technology.
Body mass index between 20 and 29 kg/m2 (female participants only).
For women with indication of utilizing autologous eggs.
Anti-Müllerian Hormone (AMH) value of at least 1.5 ng/mL.
18 - 39 years of age.
For women utilizing donor eggs (egg donor age 18-28 years).
18 - 45 years of age.
Patients diagnosed with recurrent pregnancy loss.
Inaccessible ovaries for puncture.
History of total or partial fertilization failure in a previous fertility treatment.
History of repeated implantation failure defined as three previous unsuccessful embryo transfers.
Uterine factors (e.g. fibroids, uterine surgeries, Müllerian malformations) at the discretion of the medical team and based on its impact on success and/or risk to the patient or the pregnancy may compromise treatment prognosis.
Untreated hydrosalpinx.
Severe endometriosis III, IV, presence of endometriomas and/or history of endometrioma resection.
Polycystic ovarian syndrome.
Patients with any of the following severe male factor infertility.
Sperm concentrations less than 5 million per mL.
Progressive motility less than 5%.
Others (e.g, globozoospermia and seminal infections) at the discretion of the medical team and based on its impact on success.